Trijardy XR 1000 mg/1 (Empagliflozin, Linagliptin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 1000 mg/1

Trijardy XR 1000 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for managing type 2 diabetes. This extended-release tablet supports blood sugar control and may reduce cardiovascular risks. Ideal for adults with type 2 diabetes requiring combination therapy.

Strength

1000 mg/1

Pack Size

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-13)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trijardy XR 1000 mg/1 is primarily used to manage type 2 diabetes in adults. It combines three active ingredients—empagliflozin, linagliptin, and metformin hydrochloride—to help control blood sugar levels. This medication is often prescribed for individuals who need combination therapy to achieve optimal glycemic control. It may also be used to reduce the risk of cardiovascular events in certain patients.

Side Effects

Common effects of Trijardy XR 1000 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when starting the medication. Some users may experience hypoglycemia, especially when combined with other diabetes medications. Extended-release tablets are designed to minimize these effects by releasing the medication gradually over time.

Precautions & Warnings

Trijardy XR 1000 mg/1 should be taken as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. Patients with kidney problems or a history of pancreatitis should discuss these conditions with their healthcare provider before starting this medication. Regular monitoring of blood sugar levels is recommended.

Avoid Interactions

Trijardy XR 1000 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Frequently Asked Questions

Trijardy XR 1000 mg/1 is used to manage type 2 diabetes in adults by controlling blood sugar levels.

Trijardy XR 1000 mg/1 should be taken orally, usually once daily, with a meal as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, nausea, and hypoglycemia.

Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Trijardy XR 1000 mg/1 is typically prescribed for adults with type 2 diabetes who require combination therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.